HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rimantas Daugelavicius Selected Research

tetraphenylphosphonium (tetraphenylphosphonium chloride)

1/2021Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rimantas Daugelavicius Research Topics

Disease

2Infections
09/2006 - 08/2004
1Breast Neoplasms (Breast Cancer)
01/2021
1Neoplasms (Cancer)
01/2021
1Dehydration (Water Stress)
10/2019
1Virus Diseases (Viral Diseases)
04/2005
1Acquired Immunodeficiency Syndrome (AIDS)
08/2004

Drug/Important Bio-Agent (IBA)

1tetraphenylphosphonium (tetraphenylphosphonium chloride)IBA
01/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2021
1Glutathione (Reduced Glutathione)IBA
10/2019
1Proteins (Proteins, Gene)FDA Link
09/2006
1Capsid Proteins (Capsid Protein)IBA
09/2006
1DNA (Deoxyribonucleic Acid)IBA
09/2006
1IonsIBA
04/2005
1Peptidoglycan (Murein)IBA
08/2004
1Membrane Proteins (Integral Membrane Proteins)IBA
08/2004
1LipidsIBA
08/2004
1Gramicidin (Gramicidin A)FDA LinkGeneric
08/2004

Therapy/Procedure

1Fluid Therapy (Oral Rehydration Therapy)
10/2019